| Literature DB >> 26859449 |
Simon Raffel1, Andreas Trumpp2.
Abstract
Leukemic stem cells (LSCs) are resistant to conventional chemotherapy and promote acute myeloid leukemia (AML) progression and recurrence. In this issue of Cancer Cell, Lechman and colleagues (2016) identify the microRNA miR-126 as a regulator of PI3K-AKT-mTOR and CDK3 signaling driving LSC self-renewal and chemotherapy resistance.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26859449 DOI: 10.1016/j.ccell.2016.01.007
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743